| Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies AM Shannon, DJ Bouchier-Hayes, CM Condron, D Toomey Cancer treatment reviews 29 (4), 297-307, 2003 | 729 | 2003 |
| Oncological implications of hypoxia inducible factor-1α (HIF-1α) expression JL O’Donnell, MR Joyce, AM Shannon, J Harmey, J Geraghty, ... Cancer treatment reviews 32 (6), 407-416, 2006 | 98 | 2006 |
| The mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) enhances the radiation responsiveness of lung and colorectal … AM Shannon, BA Telfer, PD Smith, M Babur, A Logie, RW Wilkinson, ... Clinical Cancer Research 15 (21), 6619-6629, 2009 | 63 | 2009 |
| Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit KJ Williams, BA Telfer, AM Shannon, M Babur, IJ Stratford, SR Wedge Molecular cancer therapeutics 6 (2), 599-606, 2007 | 63 | 2007 |
| Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma AM Shannon, DJ Bouchier-Hayes, CM Condron, D Toomey British journal of cancer 93 (2), 224-232, 2005 | 41 | 2005 |
| Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis DKR Medipally, D Cullen, V Untereiner, GD Sockalingum, A Maguire, ... Therapeutic advances in medical oncology 12, 1758835920918499, 2020 | 37 | 2020 |
| Antiangiogenics and radiotherapy AM Shannon, KJ Williams Journal of Pharmacy and Pharmacology 60 (8), 1029-1036, 2008 | 33 | 2008 |
| Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTINTM; AZD2171) enhances radiation response and causes substantial … KJ Williams, BA Telfer, AM Shannon, M Babur, IJ Stratford, SR Wedge The British Journal of Radiology 81 (special_issue_1), S21-S27, 2008 | 32 | 2008 |
| Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open … JV Reynolds, SR Preston, B O'Neill, MA Lowery, L Baeksgaard, T Crosby, ... The Lancet Gastroenterology & Hepatology 8 (11), 1015-1027, 2023 | 25 | 2023 |
| Monitoring radiotherapeutic response in prostate cancer patients using high throughput FTIR spectroscopy of liquid biopsies DKR Medipally, TNQ Nguyen, J Bryant, V Untereiner, GD Sockalingum, ... Cancers 11 (7), 925, 2019 | 25 | 2019 |
| Examining Changes in [18 F]FDG and [18 F]FLT Uptake in U87-MG Glioma Xenografts as Early Response Biomarkers to Treatment with the Dual mTOR1/2 … HG Keen, SA Ricketts, J Maynard, A Logie, R Odedra, AM Shannon, ... Molecular imaging and biology 16, 421-430, 2014 | 22 | 2014 |
| Development of a label‐free LC‐MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical … B Morrissey, C O'Shea, J Armstrong, C Rooney, L Staunton, M Sheehan, ... Proteomics–Clinical Applications 7 (5-6), 316-326, 2013 | 22 | 2013 |
| Prediction of DNA damage and G2 chromosomal radio-sensitivity ex vivo in peripheral blood mononuclear cells with label-free Raman micro-spectroscopy AD Meade, A Maguire, J Bryant, D Cullen, D Medipally, L White, ... International Journal of Radiation Biology 95 (1), 44-53, 2019 | 20 | 2019 |
| Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression PG Thirion, MT Dunne, PJ Kelly, A Flavin, JM O’Sullivan, D Hacking, ... British Journal of Cancer 122 (9), 1315-1323, 2020 | 17 | 2020 |
| An Evaluation of 2-deoxy-2-[18F]Fluoro-D-Glucose and 3′-deoxy-3′-[18F]-Fluorothymidine Uptake in Human Tumor Xenograft Models H Keen, B Pichler, D Kukuk, O Duchamp, O Raguin, A Shannon, ... Molecular imaging and biology 14, 355-365, 2012 | 16 | 2012 |
| Discovery and longitudinal evaluation of candidate protein biomarkers for disease recurrence in prostate cancer CL Tonry, D Doherty, C O’Shea, B Morrissey, L Staunton, B Flatley, ... Journal of proteome research 14 (7), 2769-2783, 2015 | 13 | 2015 |
| Raman spectroscopy of lymphocytes for the identification of prostate cancer patients with late radiation toxicity following radiotherapy D Cullen, J Bryant, A Maguire, D Medipally, B McClean, L Shields, ... Translational Biophotonics 2 (4), e201900035, 2020 | 12 | 2020 |
| Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung … RL McDermott, JG Armstrong, P Thirion, M Dunne, M Finn, C Small, ... Radiotherapy and Oncology 127 (2), 253-258, 2018 | 12 | 2018 |
| A phase II toxicity end point trial (ICORG 99-09) of accelerated dose-escalated hypofractionated radiation in non-small cell lung cancer DN Cagney, PG Thirion, MT Dunne, C Fleming, D Fitzpatrick, CM O'Shea, ... Clinical Oncology 30 (1), 30-38, 2018 | 9 | 2018 |
| Effect of hemolysis on Fourier transform infrared and Raman spectra of blood plasma DKR Medipally, D Cullen, V Untereiner, J Bryant, GD Sockalingum, ... Journal of Biophotonics 13 (7), e201960173, 2020 | 8 | 2020 |
